应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMVT Immunovant, Inc.
休市中 08-23 16:00:00 EDT
32.42
+1.02
+3.25%
盘后
32.42
+0.00
0.00%
19:18 EDT
最高
32.54
最低
31.30
成交量
50.47万
今开
31.67
昨收
31.40
日振幅
3.93%
总市值
47.45亿
流通市值
21.18亿
总股本
1.46亿
成交额
1,628万
换手率
0.77%
流通股本
6,532万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Immunovant, Inc.2024财年第二财季实现净利润-87.15百万美元,同比减少17.87%
自选股智能写手 · 08-16
Immunovant, Inc.2024财年第二财季实现净利润-87.15百万美元,同比减少17.87%
Immunovant Inc 预计每股亏损53美分 - 财报前瞻
Reuters · 08-06
Immunovant Inc 预计每股亏损53美分 - 财报前瞻
Immunovant, Inc.盘中异动 股价大跌5.63%
自选股智能写手 · 08-05
Immunovant, Inc.盘中异动 股价大跌5.63%
Immunovant, Inc.盘中异动 股价大跌5.00%
自选股智能写手 · 07-18
Immunovant, Inc.盘中异动 股价大跌5.00%
Immunovant, Inc.盘中异动 股价大涨5.11%报31.90美元
自选股智能写手 · 07-11
Immunovant, Inc.盘中异动 股价大涨5.11%报31.90美元
Immunovant, Inc.盘中异动 急速拉升5.01%
自选股智能写手 · 07-10
Immunovant, Inc.盘中异动 急速拉升5.01%
Immunovant, Inc.盘中异动 股价大涨6.34%
自选股智能写手 · 07-01
Immunovant, Inc.盘中异动 股价大涨6.34%
Immunovant, Inc.盘中异动 快速下跌5.09%
自选股智能写手 · 06-27
Immunovant, Inc.盘中异动 快速下跌5.09%
奥本海默:维持Immunovant(IMVT.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至46.
智通财经 · 06-03
奥本海默:维持Immunovant(IMVT.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至46.
Immunovant, Inc.盘中异动 下午盘急速跳水5.07%报25.07美元
自选股智能写手 · 06-01
Immunovant, Inc.盘中异动 下午盘急速跳水5.07%报25.07美元
Immunovant Inc:古根海姆将目标价格从50美元下调至48美元
智通财经 · 05-31
Immunovant Inc:古根海姆将目标价格从50美元下调至48美元
坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。
智通财经 · 05-30
坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。
坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。
智通财经 · 05-30
坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。
Immunovant, Inc.盘中异动 早盘快速跳水9.84%
自选股智能写手 · 05-30
Immunovant, Inc.盘中异动 早盘快速跳水9.84%
Immunovant, Inc.盘中异动 急速上涨9.82%报31.21美元
自选股智能写手 · 05-29
Immunovant, Inc.盘中异动 急速上涨9.82%报31.21美元
Immunovant Inc 预计每股亏损43美分 - 财报前瞻
Reuters · 05-10
Immunovant Inc 预计每股亏损43美分 - 财报前瞻
Immunovant, Inc.盘中异动 快速下跌5.00%报28.88美元
自选股智能写手 · 04-17
Immunovant, Inc.盘中异动 快速下跌5.00%报28.88美元
Immunovant(IMVT.US)获奥本海默首次覆盖,给予优于大市评级, 目标价50.00美元。
智通财经 · 03-28
Immunovant(IMVT.US)获奥本海默首次覆盖,给予优于大市评级, 目标价50.00美元。
Truist Securities:重申Immunovant(IMVT.US)评级,由买入调整至买入评级, 目标价48.00美元。
智通财经 · 03-26
Truist Securities:重申Immunovant(IMVT.US)评级,由买入调整至买入评级, 目标价48.00美元。
BUZZ-竞争对手中外制药的数据不尽如人意,Immunovant 和 Argenx 的业绩上升
Reuters · 03-22
BUZZ-竞争对手中外制药的数据不尽如人意,Immunovant 和 Argenx 的业绩上升
暂无数据
公司概况
公司名称:
Immunovant, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司,专注于为自身免疫性疾病患者提供正常生活。
发行价格:
--
{"stockData":{"symbol":"IMVT","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":32.42,"timestamp":1724443200000,"preClose":31.4,"halted":0,"volume":504724,"hourTrading":{"tag":"盘后","latestPrice":32.42,"preClose":32.42,"latestTime":"19:18 EDT","volume":18553,"amount":601506.62,"timestamp":1724455132102},"delay":0,"floatShares":65315342,"shares":146367374,"eps":-1.91941,"marketStatus":"休市中","marketStatusCode":7,"change":1.02,"latestTime":"08-23 16:00:00 EDT","open":31.67,"high":32.535,"low":31.3,"amount":16276170.46946,"amplitude":0.039331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.91941,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":31.4,"preHourTrading":{"tag":"盘前","latestPrice":31.57,"preClose":31.4,"latestTime":"08:56 EDT","volume":1350,"amount":42591.62115,"timestamp":1724417768365},"postHourTrading":{"tag":"盘后","latestPrice":32.42,"preClose":32.42,"latestTime":"19:18 EDT","volume":18553,"amount":601506.62,"timestamp":1724455132102},"volumeRatio":0.5771912898616103,"impliedVol":0.1563,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/IMVT/tweets","defaultTab":"tweets","newsList":[{"id":"2459472207","title":"Immunovant, Inc.2024财年第二财季实现净利润-87.15百万美元,同比减少17.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459472207","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459472207?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:02","pubTimestamp":1723737736,"startTime":"0","endTime":"0","summary":"8月16日,Immunovant, Inc.公布财报,公告显示公司2024财年第二财季净利润为-87.15百万美元,同比减少17.87%;其中营业收入为0.00美元,每股基本收益为-0.60美元。从资产负债表来看,Immunovant, Inc.总负债45.02百万美元,其中短期债务69000.00美元,资产负债比为0.14,流动比率为0.14。机构评级:截至2024年8月16日,当前有14家机构对Immunovant, Inc.目标价做出预测,其中目标均价为48.43美元,其中最低目标价为41.00美元,最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002299f2e441b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002299f2e441b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","IMVTW","IMVT"],"gpt_icon":0},{"id":"2457234000","title":"Immunovant Inc 预计每股亏损53美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457234000","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457234000?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:55","pubTimestamp":1722952522,"startTime":"0","endTime":"0","summary":" * Immunovant公司 在8月8日公布截至2024年6月30日的财报时,预计季度收入将没有变化() * * LSEG分析师对Immunovant公司的平均预期是每股亏损53美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 49.00 美元,高于其上次收盘价 26.71 美元。8月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Immunovant Inc 预计每股亏损53美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT"],"gpt_icon":0},{"id":"2457737897","title":"Immunovant, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457737897","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457737897?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:36","pubTimestamp":1722864960,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时36分,Immunovant, Inc.股票出现波动,股价快速下跌5.63%。截至发稿,该股报26.30美元/股,成交量3.6608万股,换手率0.03%,振幅2.73%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为1.75%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大,Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃,换手率分别为1027.94%、44.55%、13.93%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Portage Biotech Inc.,振幅分别为18.36%、17.59%、16.29%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052136009f10716a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052136009f10716a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","IMVTW","IMVTU","BK4139","IMVT"],"gpt_icon":0},{"id":"2452436702","title":"Immunovant, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452436702","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452436702?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:55","pubTimestamp":1721318145,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时55分,Immunovant, Inc.股票出现波动,股价急速下挫5.00%。截至发稿,该股报28.48美元/股,成交量28.6487万股,换手率0.20%,振幅4.90%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为2.09%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大,Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为2243.87%、2121.96%、1182.82%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235545aefa5a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235545aefa5a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","BK4585","BK4139","BK4588","IMVTU","IMVTW"],"gpt_icon":0},{"id":"2450363671","title":"Immunovant, Inc.盘中异动 股价大涨5.11%报31.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450363671","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450363671?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:36","pubTimestamp":1720704991,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时36分,Immunovant, Inc.股票出现波动,股价急速拉升5.11%。截至发稿,该股报31.90美元/股,成交量4.1287万股,换手率0.03%,振幅2.50%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Kazia Therapeutics Limited、Okyo Pharma Ltd Com Npv 、Virpax Pharmaceuticals, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为265.25%、209.46%、178.13%,振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Lexeo Therapeutics, Inc.,振幅分别为40.41%、22.94%、15.15%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213632af91dd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213632af91dd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","IMVTW","IMVTU","BK4139","IMVT"],"gpt_icon":0},{"id":"2450071112","title":"Immunovant, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450071112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450071112?lang=zh_cn&edition=full","pubTime":"2024-07-10 02:41","pubTimestamp":1720550516,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日02时41分,Immunovant, Inc.股票出现波动,股价急速上涨5.01%。截至发稿,该股报29.04美元/股,成交量44.6068万股,换手率0.31%,振幅5.55%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Soligenix, Inc.、Cingulate Inc C/Wts 10/12/2026 、180 Life Sciences Corp.涨幅较大,Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃,换手率分别为12816.63%、3133.66%、357.27%,振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为468.99%、196.29%、134.00%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100241569681b353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100241569681b353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","BK4588","IMVTU","IMVTW","BK4139","BK4585"],"gpt_icon":0},{"id":"2448914777","title":"Immunovant, Inc.盘中异动 股价大涨6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448914777","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448914777?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:26","pubTimestamp":1719847562,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时26分,Immunovant, Inc.股票出现波动,股价大幅拉升6.34%。截至发稿,该股报28.08美元/股,成交量18.278万股,换手率0.13%,振幅4.51%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。其相关个股中,Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Eyenovia, Inc.涨幅较大,Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为610.52%、171.20%、105.43%,振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为101.49%、65.56%、56.01%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232602af900ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232602af900ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTW","IMVTU","BK4139","IMVT","BK4588","BK4585"],"gpt_icon":0},{"id":"2446313713","title":"Immunovant, Inc.盘中异动 快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446313713","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446313713?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:20","pubTimestamp":1719418842,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时20分,Immunovant, Inc.股票出现异动,股价急速下跌5.09%。截至发稿,该股报25.90美元/股,成交量61.4893万股,换手率0.42%,振幅4.67%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为1.01%。其相关个股中,Anew Medical, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为673.35%、151.90%、108.22%,振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为112.12%、51.85%、45.14%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002042968171f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002042968171f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVTU","BK4588","BK4585","IMVT","IMVTW"],"gpt_icon":0},{"id":"2440467436","title":"奥本海默:维持Immunovant(IMVT.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至46.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440467436","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440467436?lang=zh_cn&edition=full","pubTime":"2024-06-03 20:26","pubTimestamp":1717417569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IMVT","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2440946665","title":"Immunovant, Inc.盘中异动 下午盘急速跳水5.07%报25.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440946665","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440946665?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:53","pubTimestamp":1717177981,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日01时53分,Immunovant, Inc.股票出现异动,股价急速下跌5.07%。截至发稿,该股报25.07美元/股,成交量131.51万股,换手率0.90%,振幅5.30%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。消息层面,截至01时53分,《坎托菲茨杰拉德公司:重申Immunovant增持评级。》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015301af8b6bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015301af8b6bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","IMVT","IMVTW","IMVTU"],"gpt_icon":0},{"id":"2439964387","title":"Immunovant Inc:古根海姆将目标价格从50美元下调至48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439964387","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439964387?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:36","pubTimestamp":1717151778,"startTime":"0","endTime":"0","summary":"Immunovant Inc:古根海姆将目标价格从50美元下调至48美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405311836189f0a4db5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405311836189f0a4db5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT"],"gpt_icon":0},{"id":"2439453624","title":"坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439453624","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439453624?lang=zh_cn&edition=full","pubTime":"2024-05-30 23:55","pubTimestamp":1717084523,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302355279f061cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302355279f061cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT"],"gpt_icon":0},{"id":"2439214546","title":"坎托菲茨杰拉德公司:重申Immunovant(IMVT.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439214546","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439214546?lang=zh_cn&edition=full","pubTime":"2024-05-30 23:45","pubTimestamp":1717083907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IMVT","BK4139","BK4588"],"gpt_icon":0},{"id":"2439426556","title":"Immunovant, Inc.盘中异动 早盘快速跳水9.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439426556","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439426556?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:31","pubTimestamp":1717075900,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时31分,Immunovant, Inc.股票出现异动,股价急速下挫9.84%。截至发稿,该股报26.66美元/股,成交量11.4432万股,换手率0.08%,振幅3.58%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Kintara Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Genfit涨幅较大,Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃,换手率分别为31.38%、21.97%、16.12%,振幅较大的相关个股有Fresh2 Group Limited、Kintara Therapeutics, Inc.、Biocardia, Inc.,振幅分别为8.11%、7.17%、7.15%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213140957a98cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213140957a98cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","IMVT","IMVTW","IMVTU","BK4585"],"gpt_icon":0},{"id":"2439593520","title":"Immunovant, Inc.盘中异动 急速上涨9.82%报31.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439593520","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439593520?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:30","pubTimestamp":1716989404,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时30分,Immunovant, Inc.股票出现波动,股价快速上涨9.82%。截至发稿,该股报31.21美元/股,成交量20.1273万股,换手率0.14%,振幅0.00%。Immunovant, Inc.股票所在的生物技术行业中,整体跌幅为1.55%。其相关个股中,Scorpius Holdings, Inc.、Ikena Oncology, Inc.、Immunovant, Inc.涨幅较大,Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃,换手率分别为71.43%、62.43%、6.33%,振幅较大的相关个股有Nanoviricides, Inc.、Immunitybio, Inc.、Zymeworks Inc.,振幅分别为5.91%、1.06%、0.00%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052921300496810839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052921300496810839&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVTW","IMVTU","BK4585","IMVT","BK4588"],"gpt_icon":0},{"id":"2434858445","title":"Immunovant Inc 预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434858445","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434858445?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:10","pubTimestamp":1715343043,"startTime":"0","endTime":"0","summary":" * Immunovant Inc 预计在5月13日公布截至2024年3月31日的业绩时,季度收入将没有变化(预计)。* * LSEG分析师对Immunovant公司的平均预期是每股亏损43美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 51.00 美元,高于其上次收盘价 29.70 美元。5月10日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT"],"gpt_icon":0},{"id":"2428234115","title":"Immunovant, Inc.盘中异动 快速下跌5.00%报28.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428234115","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428234115?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:18","pubTimestamp":1713363487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时18分,Immunovant, Inc.股票出现异动,股价快速下跌5.00%。截至发稿,该股报28.88美元/股,成交量17.5682万股,换手率0.12%,振幅4.78%。Immunovant, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。Immunovant, Inc.公司简介:Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417221808861e6bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417221808861e6bad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","IMVT","IMVTW","IMVTU"],"gpt_icon":0},{"id":"2422816511","title":"Immunovant(IMVT.US)获奥本海默首次覆盖,给予优于大市评级, 目标价50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2422816511","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422816511?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:49","pubTimestamp":1711622977,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4588","IMVT","BK4585"],"gpt_icon":0},{"id":"2422540099","title":"Truist Securities:重申Immunovant(IMVT.US)评级,由买入调整至买入评级, 目标价48.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2422540099","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422540099?lang=zh_cn&edition=full","pubTime":"2024-03-26 00:11","pubTimestamp":1711383066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","IMVT"],"gpt_icon":0},{"id":"2421025459","title":"BUZZ-竞争对手中外制药的数据不尽如人意,Immunovant 和 Argenx 的业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2421025459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421025459?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:04","pubTimestamp":1711037051,"startTime":"0","endTime":"0","summary":" 3月21日 - ** 在日本中外制药公司 报告了其自身免疫性疾病药物satralizumab的后期数据后,Immunovant 的股价上涨2.5%至32.36美元,在美国上市的Argenx 的股价上涨12.3%至401美元。** 券商 Stifel 表示,由于该药物之前的研究数据令人印象深刻,因此该数据一直是 ARGX 和 IMVT 的主要障碍。** ARGX公司的Vyvgrat已被批准用于治疗这种疾病,而IMVT公司的实验性疗法正处于后期研究阶段。** Viridian Therapeutics 和 Tourmaline Bio 的股价分别下跌了 38.8% 和 38.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BUZZ","BK4139","IMVT","VRDN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunovant.com","stockEarnings":[{"period":"1week","weight":0.0789},{"period":"1month","weight":0.1603},{"period":"3month","weight":0.1199},{"period":"6month","weight":-0.1238},{"period":"1year","weight":0.6202},{"period":"ytd","weight":-0.2305}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司,专注于为自身免疫性疾病患者提供正常生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.094855},{"month":2,"riseRate":0,"avgChangeRate":-0.169332},{"month":3,"riseRate":0.2,"avgChangeRate":-0.041053},{"month":4,"riseRate":0.4,"avgChangeRate":-0.020694},{"month":5,"riseRate":0.4,"avgChangeRate":0.099229},{"month":6,"riseRate":0.2,"avgChangeRate":-0.098266},{"month":7,"riseRate":0.5,"avgChangeRate":0.046357},{"month":8,"riseRate":0.666667,"avgChangeRate":0.116854},{"month":9,"riseRate":1,"avgChangeRate":0.165149},{"month":10,"riseRate":0.6,"avgChangeRate":0.20936},{"month":11,"riseRate":0.8,"avgChangeRate":0.09369},{"month":12,"riseRate":0.8,"avgChangeRate":0.198952}],"exchange":"NASDAQ","name":"Immunovant, Inc.","nameEN":"Immunovant, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunovant, Inc.,IMVT,Immunovant, Inc.股票,Immunovant, Inc.股票老虎,Immunovant, Inc.股票老虎国际,Immunovant, Inc.行情,Immunovant, Inc.股票行情,Immunovant, Inc.股价,Immunovant, Inc.股市,Immunovant, Inc.股票价格,Immunovant, Inc.股票交易,Immunovant, Inc.股票购买,Immunovant, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}